Summary
Cotinine is a major metabolite of nicotine in man. Its disposition kinetics has been followed in plasma and saliva from nine nonsmokers, 23 to 56 years of age. Cotinine 5, 10 and 20 mg was given intravenously and orally to each subject, and plasma, saliva and urine samples were collected for 96 h.
The kinetics of cotinine was best described by a multi-compartment model with three distinct phases both in plasma and saliva. Regardless of the mode of administration, there was no indication of dose-dependent kinetics. Mean total plasma clearance was 63.8 ml·h−1·kg−1 and mean renal clearance was 4.7 ml·h−1·kg−1, i.e. only 10% of the dose was excreted unchanged in the urine. The volume of distribution, as calculated from the plasma curves, was slightly greater than the body weight, 1.1 l·kg−1. The concentration of cotinine was 20 to 40% higher in unstimulated mixed saliva than in plasma during the absorption, distribution and elimination phases. As the clearance and distribution values in saliva were directly proportional to the corresponding values in plasma, similar terminal half-life values were obtained in the two body fluids, 15.5 and 16.8 h for plasma and saliva, respectively.
Thus the kinetics of cotinine is linear after intravenous and after oral dosing, and salivary concentrations give the same information about cotinine disposition in the body as do plasma concentrations.
Similar content being viewed by others
References
Pilotti Å (1980) Biosynthesis and mammalian metabolism of nicotine. Acta Physiol Scand [Suppl] 479: 13–17
Borzelleca JF, Bowman ER, McKennis H (1962) Studies on the respiratory and cardiovascular effects of (−)-cotinine. J Pharmacol Exp Ther 137: 313–318
Yamamoto K, Domino EF (1965) Nicotine-induced EEG and behavioral arousal. Int J Neuropharmacol 4: 359–373
Benowitz NL, Kuyt F, Jacob P, Jones RT, Osman A-L (1983) Cotinine disposition and effects. Clin Pharmacol Ther 34: 604–611
Svensson CK (1987) Clinical pharmacokinetics of nicotine. Clin Pharmacokinet 12: 30–40
Curvall M, Enzell CR (1986) Monitoring absorption by means of determination of nicotine and cotinine. Arch Toxicol [Suppl] 9: 88–102
Reference deleated
Galeazzi RL, Daenens P, Gugger M (1985) Steady-state concentation of cotinine as a measure of nicotine-intake by smokers. Eur J Clin Pharmacol 28: 301–304
Beckett AH, Gorrod JW, Jenner PJ (1972) A possible relation between pKa, and lipid solubility and the amounts excreted in urine of some tobacco alkaloids given to man. J Pharm Pharmacol 24: 115–120
Bowman ER, McKennis H (1963) (-)-Cotinine. Biochem Prep 10: 36–39
Curvall M, Kazemi Vala E, Enzell CR (1982) Simultaneous determination of nicotine and cotinine in plasma using capillary column gas chromatography with nitrogen-sensitive detection. J Chromatogr Biomed Appl 232: 368–372
Brown RD, Manno JE (1978) ESTRIP, a BASIC computer program for obtaining initial polyexponential parameter estimates. J Pharm Sci 67: 1687–1691
Benowitz NL, Jacob J (1987) Metabolism, pharmacokinetics and pharmacodynamics of nicotine in man. In: Martin RM, Van Loon GR, Iwamoto ET, Davis L (eds) Tobacco smoking and nicotine. Advances in Behavioral Biology, Vol. 31. Plenum Press, New York
Neurath GB, Dunger M, Orth D, Pein FG (1987) Trans-3′-hydroxycotinine as a main metabolite in urine of smokers. Int Arch Occup Environ Health 59: 199–201
Kyerematen GA, Damiano MD, Dvorchik BH, Vesell ES (1982) Smoking-induced changes in nicotine disposition: Application of a new HPLC assay for nicotine and its metabolites. Clin Pharmacol Ther 32: 769–780
Lynch CJ (1984) Half-lives of selected tobacco smoke exposure markers. Eur J Resp Dis [Suppl] 13: 63–67
De Schepper PJ, Van Hecken A, Van Rossum JM (1987) Kinetics of cotinine after oral and intravenous administration to man. Eur J Clin Pharmacol 31: 583–588
Langone JJ, Van Vunakis HV (1975) Quantitation of cotinine in sera of smokers. Res Commun Chem Pathol Pharmacol 10: 21–28
Sepkovic D, Haley NJ (1985) Biomedical applications of cotinine quantitation in smoking related research. Am J Public Health 75: 663–665
Gibaldi M, Perrier D (1982) Pharmacokinetics. Drugs and the pharmaceutical Science 15. Marcel Decker, New York
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Curvall, M., Elwin, CE., Kazemi-Vala, E. et al. The pharmacokinetics of cotinine in plasma and saliva from non-smoking healthy volunteers. Eur J Clin Pharmacol 38, 281–287 (1990). https://doi.org/10.1007/BF00315031
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00315031